ANAB
AnaptysBio, Inc. Common StockData: 2026-09-25
Quick Stats
Sep 25, 202647.5
AI Score
HOLD0.93
Volume Ratio
Nov 03, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
ANAB Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
ANAB Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
ANAB Options - Sort by Max open Interest (near term)
27th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ANAB Daily Out of Money Options - Sort by Max open Interest (near term)
27th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ANAB Daily In the Money Options - Sort by Max open Interest (near term)
27th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ANAB Most Active Options by Volume(near term)
27th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ANAB Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ANAB Stock Summary
Last updated Sep 25, 2026
ANAB is currently trading at $51, positioned below its 200-day moving average of $56.35, suggesting bearish momentum. The stock has a 52-week range of $20.79 to $73.3.
Technical Analysis: The 50-day moving average stands at $55.4, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.239, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.122, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ANAB at 47.5/100 with a HOLD recommendation.
ANAB (AnaptysBio, Inc. Common Stock) Indicators
Last updated Sep 25, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 35.239 |
| CMF (20) | -0.122 |
| ROC (10) | -5.328 |
| ADX (14) | 23.646 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.354 |
| AROONOSC (14) | -85.714 |
| WILLAMS %R (14) | -82.216 |
| MFI (14) | 18.674 |
ANAB Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Sep 25 | Marubozu (bearish) (contrarian — textbook says the opposite) | Bullish | 56.2% | +3.2 pts | 30540 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
AnaptysBio, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.
ANAB Moving Averages Analysis
ANAB (AnaptysBio, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Sep 25, 2026
| Days | MA |
|---|---|
| 10 | 53.57 |
| 20 | 54.78 |
| 30 | 55.95 |
| 50 | 55.4 |
| 100 | 57.79 |
| 200 | 56.35 |
ANAB Fundamental Analysis
| P/E (Forward) | 21.0084 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.5 billion |
| Earnings/Share ($) | -1.04 |
| Net Profit Margin (%) | 2.4696 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 4.7777 |
| EPS Estimate Next Year ($) | 5.5389 |
| WallStreet Target Price ($) | 88.50 |
| Most Recent Quarter |
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).